Zevra Therapeutics (ZVRA) Notes Payables (2014 - 2020)
Zevra Therapeutics' (ZVRA) quarterly Notes Payables came in at $65.9 million in Q3 2020, up 881.24% YoY from $6.7 million in Q4 2019, and down 2.01% on a QoQ basis from $67.3 million in Q2 2020.
Zevra Therapeutics (ZVRA) Notes Payables (2014 - 2020) Analysis & Trends
Zevra Therapeutics (ZVRA) has 7 years of Notes Payables data on file, last reported at $65.9 million in Q3 2020.
- Quarterly Notes Payables rose 881.24% year-over-year to $65.9 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $65.9 million (up 881.24% YoY) and the FY2019 annual result came in at $7.0 million, up 109.45% from the prior year.
- Notes Payables declined to $65.9 million in Q3 2020, from $67.3 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $68.6 million in Q1 2020 to a low of $1.6 million in Q1 2016.
- A 5-year average of $17.8 million and a median of $4.9 million in 2017 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2018 — Notes Payables changed 0.0% — and 2020, when it jumped 977.02%.
- Tracing ZVRA's Notes Payables over 5 years: stood at $1.9 million in 2016, then soared by 72.52% to $3.3 million in 2017, then changed by 0.0% to $3.3 million in 2018, then surged by 109.45% to $7.0 million in 2019, then surged by 844.3% to $65.9 million in 2020.
- The last three Notes Payables figures came in at $65.9 million (Q3 2020), $67.3 million (Q2 2020), and $68.6 million (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zevra Therapeutics | 671.75 Mn | 450.18 Mn | 38.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 65.92 Mn |
| Jun 30, 2020 | 67.27 Mn |
| Mar 31, 2020 | 68.61 Mn |
| Dec 31, 2019 | 6.98 Mn |
| Sep 30, 2019 | 6.72 Mn |
| Jun 30, 2019 | 6.50 Mn |
| Mar 31, 2019 | 6.37 Mn |
| Dec 31, 2018 | 3.33 Mn |
| Sep 30, 2018 | 3.33 Mn |
| Jun 30, 2018 | 3.33 Mn |
| Mar 31, 2018 | 3.33 Mn |
| Dec 31, 2017 | 3.33 Mn |
| Jun 30, 2016 | 1.93 Mn |
| Mar 31, 2016 | 1.65 Mn |
| Dec 31, 2015 | 1.37 Mn |
| Sep 30, 2015 | 1.10 Mn |
| Dec 31, 2014 | 325,000.00 |